INTERNATIONAL PERSPECTIVES
OECD work: reconciling social and industrial policy, empirical work, pharmacoeconomics
WHO Europe : Pricing and Reimbursement of medicines in Europe
EMEA: limited to efficacy and market approval
Approaches to regulation remain national and fragmented in Europe, even to sub-national level